Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
Liver/Kidney/CYP450: High-dose systemic copper chelate therapy requires strict monitoring of ceruloplasmin and unbound serum copper to prevent heavy metal toxicity or Wilson-like hepatic accumulation
These are dose-dependent
Track the following with each injection: Date and time of injection Injection site (specific location, e.g., left abdomen, 3 inches from navel) Dose Medication temperature (did you warm it to room temperature?) Reaction type (redness, itch, swelling, bruise, lump, pain) Reaction severity (1 to 10 scale) Reaction duration (hours or days until resolution) Treatment used Treatment effectiveness After several weeks of tracking, patterns emerge
Monitoring includes baseline and six-monthly liver function tests, NAFLD fibrosis risk stratification using FIB-4 score, and assessment for complications such as pancreatitis and gallbladder disease
Nonetheless, the high metabolic variability among individuals with ASD and comorbidity associated with other disorders have limited the development of reliable proteomic and metabolic biomarkers for diagnosis and treatment evaluation
.png)